Logo Made in Germany
presented by Logo BMWi
in cooperation with Logo AUMA
Key-Visual BioJapan 2018

BioJapan 2018

10 – 12 October 2018 – Yokohama, Japan

Meet 20 German companies

Welcome to the German Pavilion at BioJapan 2018!

BioJapan 2018
10 – 12 October 2018
Yokohama, Japan

Welcome to the German Pavilion at BioJapan 2018!

Germany is one of Europe`s most important players in the field of biotechnology.

The number of biopharmaceuticals in clinical development increased from 604 to 627 (+4%) within the year, reflecting the continued high investments in the biopharmaceutical pipeline. The pipeline increased especially strongly in the early phase of clinical development (+11% in phase I).

At BioJapan 2018 in Yokohama 20 German companies and institutions will present themselves with their ambitious product developments and services in the German official presentation at BioJapan annual convention. These companies and institutions are convinced that their products and ideas will be received with great interest.

The German Federal Ministry for Economic Affairs and Energy (BMWi), the AUMA, Association of the German Trade Industry, German Association of Biotechnology Industries of the German Chemical Industry Association (DIB) and the German Biotechnology-Industry-Organization BIO Deutschland welcome you to the official German Presentation at BioJapan 2018 in Yokohama.

Exhibitors at the German Pavilion


Iris Biotech GmbH
Diazirine Amino Acids for Photo Cross-Linkage in Living Cells
Booth number: D-35-10

Intana Bioscience GmbH
siPOOL: complex mix of siRNAs agains target gene incl pos. and neg. Control
Booth number: D-35-03

Bicoll GmbH
Natural based medicinal chemistry
Booth number: D-35-18

SIRION Biotech GmbH
Booth number: D-35-17

PAN-Biotech GmbH
Serum-free Media
Booth number: D-35-13

SIRION Biotech GmbH
Booth number: D-35-17

View all German exhibitors and products

News & Innovations

Next-generation AAV gene therapy from joined German forces
SIRION Biotech GmbH and Heidelberg University Hospital sign alliance deal for development of novel AAV capsids and technologies addressing shortcomings of clinical gene therapy trials. The viral vector specialist SIRION Biotech GmbH today announces the signing of a preferred partnership agreeme... | Further reading

LEUKOCARE and Boehringer Ingelheim enter into a long-term agreement in the field of animal health
The biotechnology company LEUKOCARE AG and Boehringer Ingelheim have entered into a license agreement in the field of veterinary diagnostics. Under the terms of this agreement, Boehringer Ingelheim will have access to LEUKOCARE`s SPS ® technologies. LEUKOCARE has established another import... | Further reading

11th BioVaria Sees Record Attendance
Startup Awards go to OPSYON and LIfT Biosciences 26 April 2018, Munich, Germany – Over 250 innovative minds gathered in Munich on April 23-24 for the 11th BioVaria to discuss emerging life-science trends and initiate partnerships between academia and industry. 63 peer-selected, patent-protected ... | Further reading

News & Innovations
Your personal organizer

Your personal organizer

Print list  |  Save as PDF